Shire Makes Its Case Against a Deal With AbbVie CHAD BRAY The Irish drug maker Shire said that as an independent company it could more than double its revenue in the next seven years, adding that it expected double-digit sales growth each year from its current portfolio of drugs. June 23, 2014 at 4:00AM http://nyti.ms/1yEO5ZC The New York Times Business Day Corporate Taxes, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1yEO5ZC Shire Makes Its Case Against a Deal With AbbVie June 23, 2014 at 4:00AM The New York Times